DG
Daina Graybosch Leerink Partners Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
7
Avg Return
Past Year
Past Year
281%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
33.3%
Neutral
55.6%
Negative
11.1%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Market Perform
Downgraded
| $115 |
0%
downside
| 1 | – |
–
| 24 Feb ‘26 2 months ago |
|
|
|
Market Perform
Downgraded
| $2 |
10%
downside
| 1 | – |
–
| 17 Nov ‘25 5 months ago |
|
|
|
Outperform
Initiated
| $9 |
267%
upside
| 1 | -31% |
0
%
| 3 Oct ‘25 6 months ago |
|
|
|
Market Perform
Downgraded
| $2 |
42%
upside
| 1 | – |
–
| 18 Sep ‘25 7 months ago |
|
|
|
Outperform
Initiated
| $2 |
76%
downside
| 1 | +1,014% |
0
%
| 6 Aug ‘25 8 months ago |
|
|
|
Outperform
Initiated
| $7 |
90%
upside
| 1 | +117% |
0
%
| 6 Aug ‘25 8 months ago |
|
|
|
Underperform
Initiated
| $12 |
46%
downside
| 1 | +25% |
0
%
| 11 Jun ‘25 10 months ago |
|
|
|
Market Perform
Downgraded
| $9 |
11%
downside
| 1 | – |
–
| 14 May ‘25 11 months ago |
|
|
|
Market Perform
Downgraded
| $0.3900 |
115%
upside
| 1 | – |
–
| 13 May ‘25 11 months ago |
|